These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38395318)

  • 1. The impact of diluents on the compaction, dissolution, and physical stability of amorphous solid dispersion tablets.
    Yu D; Hoag SW
    Int J Pharm; 2024 Apr; 654():123924. PubMed ID: 38395318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of Surfactants on Itraconazole-Hydroxypropyl Methylcellulose Acetate Succinate Solid Dispersion Prepared by Hot Melt Extrusion III: Tableting of Extrudates and Drug Release From Tablets.
    Solanki NG; Kathawala M; Serajuddin ATM
    J Pharm Sci; 2019 Dec; 108(12):3859-3869. PubMed ID: 31542437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
    Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
    AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface Characterization as a Tool for Identifying the Factors Affecting the Dissolution Rate of Amorphous Solid Dispersion Tablets.
    Yu D; Fiddler F; Ibrahim A; Sanedrin R; Tremblay H; Hoag SW
    AAPS PharmSciTech; 2022 Oct; 23(8):282. PubMed ID: 36253562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive evaluation of polymer types and ratios in Spray-Dried Dispersions: Compaction, Dissolution, and physical stability.
    Yu D; Nie H; Hoag SW
    Int J Pharm; 2024 Jan; 650():123674. PubMed ID: 38061497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formulating Amorphous Solid Dispersions: Impact of Inorganic Salts on Drug Release from Tablets Containing Itraconazole-HPMC Extrudate.
    Takano R; Maurer R; Jacob L; Stowasser F; Stillhart C; Page S
    Mol Pharm; 2020 Aug; 17(8):2768-2778. PubMed ID: 31794228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downstream processing of spray-dried ASD with hypromellose acetate succinate - Roller compaction and subsequent compression into high ASD load tablets.
    Sauer A; Warashina S; Mishra SM; Lesser I; Kirchhöfer K
    Int J Pharm X; 2021 Dec; 3():100099. PubMed ID: 34765966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the dissolution characteristics of capsule and tablet dosage forms of melt granulations of paracetamol--diluent effects.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(1):73-9. PubMed ID: 17665854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative Humidity Cycling: Implications on the Stability of Moisture-Sensitive Drugs in Solid Pharmaceutical Products.
    Veronica N; Heng PWS; Liew CV
    Mol Pharm; 2023 Feb; 20(2):1072-1085. PubMed ID: 36480246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a multiparticulate drug delivery system for in situ amorphisation.
    Holm TP; Kokott M; Knopp MM; Boyd BJ; Berthelsen R; Quodbach J; Löbmann K
    Eur J Pharm Biopharm; 2022 Nov; 180():170-180. PubMed ID: 36191869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved tabletability after a polymorphic transition of delta-mannitol during twin screw granulation.
    Vanhoorne V; Bekaert B; Peeters E; De Beer T; Remon JP; Vervaet C
    Int J Pharm; 2016 Jun; 506(1-2):13-24. PubMed ID: 27094358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tableting behavior of freeze and spray-dried excipients in pharmaceutical formulations.
    Madi C; Hsein H; Busignies V; Tchoreloff P; Mazel V
    Int J Pharm; 2024 May; 656():124059. PubMed ID: 38552753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of multi-component tablets containing co-amorphous salts: Combining multimodal non-linear optical imaging with established analytical methods.
    Ojarinta R; Saarinen J; Strachan CJ; Korhonen O; Laitinen R
    Eur J Pharm Biopharm; 2018 Nov; 132():112-126. PubMed ID: 30248394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.
    Indulkar AS; Lou X; Zhang GGZ; Taylor LS
    Mol Pharm; 2019 Mar; 16(3):1327-1339. PubMed ID: 30669846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roller compaction, granulation and capsule product dissolution of drug formulations containing a lactose or mannitol filler, starch, and talc.
    Chang CK; Alvarez-Nunez FA; Rinella JV; Magnusson LE; Sueda K
    AAPS PharmSciTech; 2008; 9(2):597-604. PubMed ID: 18459052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High Bulk-Density Amorphous Dispersions to Enable Direct Compression of Reduced Tablet Size Amorphous Dosage Units.
    Frank DS; Nie H; Chandra A; Coelho A; Dalton C; Dvorak H; Elkhabaz A; Fahy M; Ormes J; Parker A; Punia A; Rowe J; Schenck L; Smith D; Strotman NA; Wang M; Wareham L
    J Pharm Sci; 2023 Aug; 112(8):2037-2045. PubMed ID: 36115592
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detrimental Effect of the Film Coat Chemistry and Thickness on the Physical Stability of Amorphous Solid Dispersions in Tablet Formulations.
    Punia A; Biyyala V; Faassen F; Ash J; Lamm MS
    J Pharm Sci; 2023 Mar; 112(3):708-717. PubMed ID: 36189478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical development of an amorphous solid dispersion formulation of elacridar hydrochloride for proof-of-concept clinical studies.
    Sawicki E; Schellens JH; Beijnen JH; Nuijen B
    Drug Dev Ind Pharm; 2017 Apr; 43(4):584-594. PubMed ID: 28010129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of an Amorphous Solid Dispersion Formulation for Mitigating Mechanical Instability of Crystalline Form and Improving Bioavailability for Early Phase Clinical Studies.
    Chiang CW; Lubach JW; Chen T; Chin S; Ly J; Zhang W; Hou HH; Nagapudi K
    Mol Pharm; 2023 May; 20(5):2452-2464. PubMed ID: 37010134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formulation-dependent stability mechanisms affecting dissolution performance of directly compressed griseofulvin tablets.
    Maclean N; Khadra I; Mann J; Abbott A; Mead H; Markl D
    Int J Pharm; 2023 Jan; 631():122473. PubMed ID: 36493970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.